A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL MICROBIOLOGY
Volume 66, Issue 9, Pages 1261-1274
Publisher
Microbiology Society
Online
2017-08-31
DOI
10.1099/jmm.0.000565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design
- (2017) Jozlyn R. Clasman et al. Scientific Reports
- Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia
- (2017) Mohammad Khalid et al. ANNALS OF SAUDI MEDICINE
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
- (2016) Mizuki Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
- (2016) Hongjie Qiu et al. ANTIVIRAL RESEARCH
- Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia
- (2016) Mohammed Al Ghamdi et al. BMC INFECTIOUS DISEASES
- MERS-CoV spike protein: a key target for antivirals
- (2016) Lanying Du et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- (2016) Jaffar A. Al-Tawfiq et al. Expert Review of Anti-Infective Therapy
- A review of treatment modalities for Middle East Respiratory Syndrome
- (2016) Yin Mo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
- (2016) Katherine V. Houser et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants
- (2016) Wanbo Tai et al. JOURNAL OF VIROLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- MERS-CoV vaccine candidates in development: The current landscape
- (2016) Kayvon Modjarrad VACCINE
- 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
- (2016) Reed F. Johnson et al. VIROLOGY
- Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
- (2016) Anurodh Shankar Agrawal et al. Scientific Reports
- Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission
- (2016) Zhao Zhang et al. Scientific Reports
- Cross host transmission in the emergence of MERS coronavirus
- (2016) Chantal BEM Reusken et al. Current Opinion in Virology
- Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
- (2016) Davide Corti et al. Journal of Infection and Public Health
- Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel
- (2016) Hanan H. Balkhy et al. Journal of Infection and Public Health
- Notes from the Field: Nosocomial Outbreak of Middle East Respiratory Syndrome in a Large Tertiary Care Hospital — Riyadh, Saudi Arabia, 2015
- (2016) Hanan H. Balkhy et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
- (2016) Chan-Ki Min et al. Scientific Reports
- Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
- (2015) Hyun Lee et al. ACS Chemical Biology
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
- (2015) Kai-Wen Cheng et al. ANTIVIRAL RESEARCH
- Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report
- (2015) Uh Jin Kim et al. ANTIVIRAL THERAPY
- A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
- (2015) Yan Li et al. CELL RESEARCH
- Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
- (2015) Naru Zhang et al. Cellular & Molecular Immunology
- Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
- (2015) Xiaojuan Guo et al. IMMUNOLOGY
- IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
- (2015) Sarah Shalhoub et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
- (2015) Rudragouda Channappanavar et al. JOURNAL OF INFECTIOUS DISEASES
- Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
- (2015) Hin Chu et al. JOURNAL OF INFECTIOUS DISEASES
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- High Secretion of Interferons by Human Plasmacytoid Dendritic Cells upon Recognition of Middle East Respiratory Syndrome Coronavirus
- (2015) Vivian A. Scheuplein et al. JOURNAL OF VIROLOGY
- A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
- (2015) Anna H. Malczyk et al. JOURNAL OF VIROLOGY
- Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
- (2015) Asisa Volz et al. JOURNAL OF VIROLOGY
- Glycosylation of Mouse DPP4 Plays a Role in Inhibiting Middle East Respiratory Syndrome Coronavirus Infection
- (2015) Kayla M. Peck et al. JOURNAL OF VIROLOGY
- 2014 MERS-CoV Outbreak in Jeddah — A Link to Health Care Facilities
- (2015) Ikwo K. Oboho et al. NEW ENGLAND JOURNAL OF MEDICINE
- An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
- (2015) B. L. Haagmans et al. SCIENCE
- A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
- (2015) Karuppiah Muthumani et al. Science Translational Medicine
- MERS coronavirus: diagnostics, epidemiology and transmission
- (2015) Ian M. Mackay et al. Virology Journal
- Receptor-binding domain-based subunit vaccines against MERS-CoV
- (2015) Naru Zhang et al. VIRUS RESEARCH
- Origin and Possible Genetic Recombination of the Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China: Phylogenetics and Coalescence Analysis
- (2015) Yanqun Wang et al. mBio
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Evaluation of candidate vaccine approaches for MERS-CoV
- (2015) Lingshu Wang et al. Nature Communications
- The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses
- (2015) Diego Forni et al. Scientific Reports
- Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
- (2015) Xiaojuan Yu et al. Scientific Reports
- Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets
- (2015) Yang Yang et al. Scientific Reports
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
- (2015) Yaseen Arabi et al. SpringerPlus
- Critical Assessment of the Important Residues Involved in the Dimerization and Catalysis of MERS Coronavirus Main Protease
- (2015) Bo-Lin Ho et al. PLoS One
- Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Yaseen M. Arabi et al. ANNALS OF INTERNAL MEDICINE
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
- (2014) Jian Lei et al. ANTIVIRAL RESEARCH
- Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases
- (2014) Mohammed Khalid et al. ANTIVIRAL THERAPY
- Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States
- (2014) Minal Kapoor et al. CLINICAL INFECTIOUS DISEASES
- An Observational, Laboratory-Based Study of Outbreaks of Middle East Respiratory Syndrome Coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014
- (2014) C. Drosten et al. CLINICAL INFECTIOUS DISEASES
- Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen
- (2014) Nikolaos Spanakis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- (2014) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Rooting the Phylogenetic Tree of Middle East Respiratory Syndrome Coronavirus by Characterization of a Conspecific Virus from an African Bat
- (2014) V. M. Corman et al. JOURNAL OF VIROLOGY
- Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4
- (2014) N. van Doremalen et al. JOURNAL OF VIROLOGY
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
- (2014) Tianlei Ying et al. JOURNAL OF VIROLOGY
- A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
- (2014) L. Du et al. JOURNAL OF VIROLOGY
- Towards improving clinical management of Middle East respiratory syndrome coronavirus infection
- (2014) Frederick G Hayden et al. LANCET INFECTIOUS DISEASES
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
- (2014) Ali S Omrani et al. LANCET INFECTIOUS DISEASES
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
- (2014) L. Jiang et al. Science Translational Medicine
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response
- (2014) Hin Chu et al. VIROLOGY
- Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
- (2014) Lu Lu et al. Nature Communications
- Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study
- (2014) Renee W Y Chan et al. Lancet Respiratory Medicine
- Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
- (2013) Jan Felix Drexler et al. ANTIVIRAL RESEARCH
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- Hyperimmune IV Immunoglobulin Treatment
- (2013) Ivan F.N. Hung et al. CHEST
- Adjunctive therapies and immunomodulating agents for severe influenza
- (2013) David S. C. Hui et al. Influenza and Other Respiratory Viruses
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
- (2013) Hisham Momattin et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease
- (2013) X. Yang et al. JOURNAL OF GENERAL VIROLOGY
- Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
- (2013) S. K. P. Lau et al. JOURNAL OF GENERAL VIROLOGY
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment
- (2013) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
- (2013) Jie Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus
- (2013) V. S. Raj et al. JOURNAL OF VIROLOGY
- Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2
- (2013) Kazuya Shirato et al. JOURNAL OF VIROLOGY
- Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody
- (2013) K. Ohnuma et al. JOURNAL OF VIROLOGY
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
- (2013) S. Gierer et al. JOURNAL OF VIROLOGY
- Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
- (2013) Abdullah Assiri et al. LANCET INFECTIOUS DISEASES
- Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
- (2013) Chantal BEM Reusken et al. LANCET INFECTIOUS DISEASES
- Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
- (2013) Bart L Haagmans et al. LANCET INFECTIOUS DISEASES
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
- (2013) Darryl Falzarano et al. NATURE MEDICINE
- Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
- (2013) Abdullah Assiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
- (2013) Zhaohui Qian et al. PLoS One
- A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
- (2013) Lanying Du et al. PLoS One
- Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
- (2013) T. Scobey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
- (2013) Darryl Falzarano et al. Scientific Reports
- Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
- (2013) Everett Clinton Smith et al. PLoS Pathogens
- The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
- (2013) Yang Yang et al. Protein & Cell
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
- (2012) Sandrine Belouzard et al. Viruses-Basel
- Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines
- (2012) M. A. Muller et al. mBio
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
- (2012) S. van Boheemen et al. mBio
- Corticosteroid Treatment in Critically Ill Patients with Pandemic Influenza A/H1N1 2009 Infection
- (2011) Sung-Han Kim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species Transmission
- (2009) R. L. Graham et al. JOURNAL OF VIROLOGY
- Cytokine Responses in Porcine Respiratory Coronavirus-Infected Pigs Treated with Corticosteroids as a Model for Severe Acute Respiratory Syndrome
- (2008) X. Zhang et al. JOURNAL OF VIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started